Chappell, W.H., Steelman, L.S., Long, J.M., Kempf, R.C., Abrams, S.L., Franklin, R.A., et al. (2011). Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health. ONCOTARGET, 2(2), 135-164.

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health.

MONTALTO, Giuseppe;
2011-01-01

2011
Chappell, W.H., Steelman, L.S., Long, J.M., Kempf, R.C., Abrams, S.L., Franklin, R.A., et al. (2011). Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health. ONCOTARGET, 2(2), 135-164.
File in questo prodotto:
File Dimensione Formato  
oncotarget review.pdf

Solo gestori archvio

Dimensione 810.79 kB
Formato Adobe PDF
810.79 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/77644
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 503
  • ???jsp.display-item.citation.isi??? 463
social impact